Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 18/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3276611 | 0.88 | F10 (0.67) | F10ABCB11F2ST14PTGS2 | |
| SCHEMBL78971 | 0.88 | F10 (0.67) | F10ABCB11F2ST14PTGS2 | |
| SCHEMBL2233431 | 0.88 | F10 (0.67) | F10ABCB11F2ST14PTGS2 | |
| SCHEMBL14838723 | 0.80 | F10 (0.56) | F10ABCB11F2ST14PTGS2 | |
| SCHEMBL14838626 | 0.79 | F10 (0.67) | F10ABCB11F2ST14PTGS2 | |
| SCHEMBL14838648 | 0.78 | F10 (0.53) | F10ABCB11F2ST14PTGS2 | |
| SCHEMBL10001459 | 0.78 | F10 (0.65) | F10ABCB11F2ST14PTGS2 | |
| SCHEMBL13739574 | 0.78 | PTGS2 (0.56) | F10PTGS2 | |
| SCHEMBL454994 | 0.78 | PTGS2 (0.56) | F10PTGS2 | |
| SCHEMBL117112 | 0.78 | PTGS2 (0.56) | F10PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023088229-A1 | METHOD FOR SYNTHESIZING RIVAROXABAN | 浙江华海药业股份有限公司 | 2023-05-25 | — | — | WO | disclosed |